Signaling Pathways - constitutive androstane receptor (CAR) - Ubiquitin-activating Enzyme E1 - Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) - FGFR
清除全部
-
A8706 BLU9931Target: FGFRSummary: 有效的FGFR4不可逆抑制剂 -
B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: 酪氨酸激酶抑制剂(TKI) -
B4904 ACTB-1003Target: VEGFR|FGFR|Tie-2|RSK|p70 S6KSummary: FGFR1抑制剂 -
A8696 FIIN-2Target: FGFRSummary: FGFR抑制剂 -
B7468 CITCO1 CitationTarget: constitutive androstane receptor (CAR)Summary: 组成型雄激素受体（CAR）激动剂 -
B1036 MLN49245 CitationTarget: NAE|Ubiquitin-activating Enzyme E1|SUMOylationSummary: NAE抑制剂 -
B1244 PYZD-4409Target: Ubiquitin-activating Enzyme E1Summary: 泛素激活酶E1抑制剂 -
A8350 AZD4547Target: FGFRSummary: FGFR抑制剂 -
A2024 PD168393Target: PDGFR|FGFR|EGFR|PKC|insulinSummary: EGFR抑制剂 -
A5467 Ponatinib (AP24534)1 Citation中文名: 帕纳替尼Target: VEGFR|PDGFR|Bcr-Abl|FGFR|SrcSummary: pan-BCR-ABL抑制剂，多激酶抑制剂